Literature DB >> 2862829

Interactions of cholecystokinin and dopamine in the nucleus accumbens.

R Y Wang, F J White, M M Voigt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862829     DOI: 10.1111/j.1749-6632.1985.tb29930.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry.

Authors:  K Seroogy; M Schalling; S Brené; A Dagerlind; S Y Chai; T Hökfelt; H Persson; M Brownstein; R Huan; J Dixon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.

Authors:  Samuel B Kombian; Kethireddy V V Ananthalakshmi; Subramanian S Parvathy; Wandikayi C Matowe
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

3.  Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration.

Authors:  T Suzuki; T Moroji
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 4.  Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction.

Authors:  Cristina Cadoni
Journal:  Front Neurosci       Date:  2016-02-09       Impact factor: 4.677

5.  A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology.

Authors:  Malgorzata Marta Drozd; Maria Capovilla; Carlo Previderé; Mauro Grossi; Florence Askenazy; Barbara Bardoni; Arnaud Fernandez
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.